Cash - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Cash Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Cash Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Cash
zł20m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medicofarma Biotech SA
WSE:MDB
Cash
zł507.6k
CAGR 3-Years
194%
CAGR 5-Years
8%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Cash
zł44.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Cash?
Cash
20m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Cash amounts to 20m PLN.

What is Ryvu Therapeutics SA's Cash growth rate?
Cash CAGR 3Y
-45%

Over the last year, the Cash growth was 132%. The average annual Cash growth rates for Ryvu Therapeutics SA have been -45% over the past three years .

Back to Top